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Background: The Respiratory Quotient is a parameter reflecting the utilization of the nutrients by a subject. It is
associated with an high rate of subsequent weight gain and with the atherosclerosis. Subjects tending to burn less
fat have an increased Respiratory Quotient. Aim of this study was to investigate on the relationship between the
Respiratory Quotient and the cardiovascular risk factors.
Methods: In this cross-sectional study we enrolled 223 individuals of both sexes aged 45–75 ys that were weight
stable, receiving a balanced diet, and not affected by debilitating disease or cardiovascular disease. The Respiratory
Quotient was measured by Indirect Calorimetry. The measurement of the Blood Pressure was obtained by a
mercury sphygmomanometer.
Results: We enrolled 133 female and 90 male. Systolic blood pressure only was positively correlated to the
Respiratory Quotient in univariate and multivariate regression analysis (p=0,017). The prevalence of hypertension
was significatively different between the quartiles of the Respiratory Quotient, with the highest prevalence in the IV
quartile (p=0,024).
Conclusion: High value of the Respiratory Quotient, an index of nutrients utilization, is associated to an high
prevalence of Hypertension. It is possible that in the subjects with high Respiratory Quotient and high body mass
index, the activation of the renin angiotensin system, in concert to the reduction of the utilization of the
endogenous fat stores, could increase the risk of hypertension.
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According to the current demographic projections it is
expected an increase in the cardiovascular diseases (CVDs)
incidence; therefore more sensitive predictors of the risk of
the CVDs are needed. In this regard, the Respiratory Quo-
tient (RQ), the ratio between carbon dioxide production
and oxygen consumption, reflecting the utilization of the
nutrients in a subject [1] may have an important role. In
fact, it is well known that after an overnight fast, a subject
receiving a balanced diet, that meets the energy require-
ments for the weight maintenance, burns fat as main sub-
strate; as consequence the value of RQ, usually, results
close to 0.85 [1,2]. It has been also shown that subjects* Correspondence: tmontalcini@unicz.it
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reproduction in any medium, provided the ortending to burn more glucose, but less fat, have an in-
creased value of RQ [3,4]. Moreover an high RQ is associ-
ated with an high rate of subsequent weight gain [2]
and with an increased Carotid Intima-Media Thickness
(CIMT), a well known predictor of cardiovascular events
[5], in overweight/obese individuals of both sexes [6].
At this time, whether RQ is also associated with the
cardiovascular risk factors is not fully clarified, therefore
aim of this study was to investigate on the relationship
between the RQ and the cardiovascular isk factors in in-
dividuals of both sexes.Method
In our cross-sectional study, we consecutively enrolled
223 individuals among a total of 250 evaluated from
January 2011 to September 2012, all undergoing the nutri-
tional screening tests including an Indirect Calorimetrytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ment, at our Clinical Nutrition Unit. The population in-
cluded both gender, having more than 45 years, with a
wide range of body mass index (BMI), and participating in
the study on the adherence to Mediterranean Diet and
body composition (approved by local ethical committee,
projects codes 2011.4; 2013-1/CE ). We enrolled subjects
who were weight stable in the four weeks preceding the
screening tests, who were following a nutritionally bal-
anced diet meeting energy requirements (i.e.: a solid-food
diet that supplied 50% of the calories as carbohydrate, 30%
as fat, and 20% as protein), as resulted from the nutritional
intake assessment.
According to the medical history, physical examin-
ation and blood screening tests, we enrolled apparently
healthy individuals. We excluded individuals having
clinical evidence of debilitating diseases, (cancer, severe
renal failure, sever liver insufficiency, chronic obstruct-
ive pulmonary disease), thyroid dysfunction, and car-
diovascular disease (myocardial infarction, stroke).
We excluded also subjects taking antiobesity medica-
tions, psychotropic drugs and chronotropic agents.
Furthermore, we excluded individuals following who
practiced a regular physical exercise program, who had
recently changed the use of tobacco (in the previous
four months) and smokers. To avoid the presence of in-
dividuals with alterations of the pulmonary ventilation
we excluded from the statistical analysis, those having
an RQ value over 1.00 or under 0.70 (normal range of
RQ: 1.00 to 0.70) [7-9]. The following criteria were used
to define the distinct cardiovascular risk factors; dia-
betes: fasting blood glucose ≥126 mg/dl or antidiabetic
treatment; hyperlipidemia: total cholesterol >200 mg/dl
and/or triglycerides >200 mg/dl or lipid lowering drugs
use; hyperuricemia: serum urate concentration > 7 mg/dl
or urate lowering drugs use; hypertension: systolic
blood pressure ≥140 mmHg and/or diastolic blood pres-
sure ≥90 mmHg or antihypertensive treatment; over-
weight: BMI ≥ 25 <30 Kg/m2; obesity: body mass
index ≥30 kg/m2; smoking: current smokers or past
smokers (at least before the previous four months)
[10,11]. Furthermore, if at least 3 of the NCEP criteria
were present [12], the subjects were identified as having
the Metabolic Syndrome (MetS).
All tests were performed after a 12 h overnight
fasting. Before tests, we gave no particular suggestions
on the menu for the meal, but we requested that
the dinner before the experiments would have to in-
clude types of foods and drinks usually consumed. In-
deed they have no caffeinated beverages between their
evening meal and the conclusion of the tests on the ex-
amination’s morning. Written informed consent was
obtained. The investigation conforms to the principles
outlined in the Declaration of Helsinki.Nutritional intake and anthropometric measurements
The participant’s nutritional intake was calculated using
the nutritional software MetaDieta 3.0.1 (Meteda srl,
S. Benedetto del Tronto, Italy). Body weight was measured
before breakfast with the subjects lightly dressed, sub-
tracting the weight of clothes. Body weight was measured
with a calibrated scale and height measured with a wall-
mounted stadiometer. BMI was calculated with the follow-
ing equation: weight (kg) /height (m)2. Waist and hip
circumferences (WC and HC) were measured with a
nonstretchable tape over the unclothed abdomen at the
narrowest point between the costal margin and iliac crest
and over light clothing at the level of the widest diameter
around the buttocks, respectively, as described in the past
[13]. Bioelectrical impedance analysis (BIA) (BIA-101;
Akernsrl, Florence, Italy) was performed to estimate the
Total Body Water (TBW), Fat Mass (FM), Muscle Mass
(MM), and total Fat-Free Mass (FFM) [14].
Blood pressure measurement
The measurement of the systemic BP of both arms was
obtained by a mercury sphygmomanometer(systolic blood
pressure - SBP and diastolic blood pressure - DBP) as pre-
viously described [14,15]. Clinic BP was obtained in the
supine patients, after 5 min of quiet rest. A minimum of
three BP readings were taken using an appropriate BP cuff
size (the inflatable part of the BP cuff covered about 80
percent of the circumference of upper arm).
RQ and RMR measurement
Fasting RQ and RMR were measured with the participants
in their postabsorptive state in a sedentary position. Re-
spiratory gas exchange was measured by Indirect Calorim-
etry using the open circuit technique between the hours of
7 AM and 8:30 AM after 48-h abstention from exercise.
The Indirect Calorimetry instrument (Viasys Healthcare,
Hoechberg, Germany) was used for all measurements.
The participant rested quietly for 30 min in an isolated
room with temperature controlled (21–24°C) environ-
ment. The subject was then placed in a ventilated hood
for at least 30 min, until steady state was achieved. Criteria
for a valid measurement was a minimum of 15 min of
steady state, with steady state determined as less than 10%
fluctuation in minute ventilation and oxygen consumption
and less than 5% fluctuation in RQ. RQ was calculated as
CO2 production/O2 consumption [16].
Biochemical evaluation
Venous blood was collected after fasting overnight into
vacutainer tubes (Becton & Dickinson) and centrifuged
within 4 h. Serum glucose, creatinine, total cholesterol,
high density lipoprotein (HDL)-cholesterol, triglycerides,
uric acid were measured with Enzymatic colorimetric test.
Quality control was assessed daily for all determinations.
Table 2 Multivariate analysis – factors correlated to RQ
Variables*§ B SE beta t p
SBP 0,771 0,038 0,187 2,411 0,017
* the variables included in the model I were: RMR (ns), glucose(ns), triglyceride
(ns), SBP, DBP(ns).
§ the variables included in the model II were: RMR (ns), glucose(ns),
triglyceride(ns), SBP, DBP(ns), MetS (ns).
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Data are reported as mean ± S.D. The T-test and ANOVA
were used to compare the means between groups. The χ2-
test was used to compare the prevalence among the
groups. The univariate analysis was used to determine all
the factors correlated to the RQ. In this analysis the fol-
lowing factors were included: age, SBP, DBP, BMI, WC,
HC, TBW, FM, MM, FFM, RMR, glucose, total choles-
terol, triglycerides, HDL-cholesterol, creatinin, uric acid.
The multivariate stepwise regression analysis was used to
test for confounding variables. In particular, the variables
included in this analisys were all that correlated to the RQ
at univariate analisys with a p < 0,1 (model I); furthermore,
in a second model (model II) we included also the pres-
ence of the Metabolic Syndrome (MetS) per sè.
Individuals with incomplete data were excluded from
analisys. Significant differences were assumed to be present
at P < 0.05. All comparisons were performed using the
SPSS 17.0 for Windows (Chicago, USA).Results
In this study we enrolled 133 female and 90 male with a
mean age of 53 ± 12 ys with complete data. There were no
differences in RQ value between gender (p= 0,26), there-
fore all the analyses were performed in the overall popula-
tion. At univariate analysis we found a positive relation
(with a p < 0,1) between RQ and RMR, glucose, triglycer-
ide, SBP and DBP (Table 1). The multivariate regression
analysis confirmed that SBP only was correlated to RQ
(Table 2, model I). This correlation was confirmed after
the presence of the MetS was included in this analysis
(Table 2, model II, data not shown). Table 3 shows the
characteristics of the population according to RQ quartiles.
A significant difference in the prevalence of hypertension
was showed between groups, with the highest prevalence in
the IV quartile (Figure 1; Table 3). The ANOVA test con-
firmed that SBP was the only factors significatively different
between quartiles (I vs IV ; II vs IV quartile) (Table 3).
Discussion
The main finding of this study was the direct correlation
between RQ and SBP and RMR (Table 1) and the high
prevalence of hypertension among individuals with the






DBP 0,128 0,095for the confounding factors, the RQ remains correlated
to SBP.
In particular, subjects with an RQ higher than 0,90 (IV
RQ quartile) had an high prevalence of hypertension
(47%) unless their metabolic risk profile was similar to
that of the other quartiles (i.e. 40% male, mean age ~ 53
ys and mean BMI ~ 32 Kg/m2; tab 3).
This is a novel finding, never investigated to date and
very intriguing. It is well known that RQ is associated
with a high rate of subsequent weight gain [2,17]. Indeed
the obesity rarely exists as an isolated condition, but it is
frequently associated with hypertension [18]. Therefore
one possible explanation of the link between the high
RQ and hypertension may be a high BMI among the
subjects with high RQ, [2,19], but in our study the simi-
lar BMI among quartiles would reject this explanation.
Thus, we infer the presence of other mechanisms like
the activation of the Renin Angiotensin System (RAS)
[19-27], that results to be associated to the mechanisms
of lipid oxidation. Several experiments on mice lacking
the Angiotensin II receptor showed, in fact, an increase
in the fat utilization and a parallel reduction of the fat
mass [28], corroborating the association between hyper-
tension and the index of low fat utilization in our inves-
tigation. In addition, a study has shown that in mice
with myocardial hypertrophy, the genes associated with
the transport and breaking down of the fatty acids are
less active than in normal mice [29]. Thus, it is possible
to theorize that the failure in the fat utilization may be a
predictor of the development of CVDs in individuals
with hypertension [29].
It is well accepted that the cardiovascular risk factors
are excellent predictors of the CVDs and that their pres-
ence may lead to the abnormalities in the structure and
function of the cardiovascular system, by a number of
complex mechanisms [11,30-34].
We believe that, if confirmed by further investigations,
also high RQ may have a role in the clinical practice be-
cause it has the potential to identify the effect of the modi-
fication in the nutrients utilization on the vascular system.
Understanding this concept may give a new view on the
mechanisms of the organ damage and their prevention
and treatment. Consequently, the RQ measurement may
contribute to important changes in the prediction of car-
diovascular disease. RQ evaluation probably may identify
the individuals needing special therapeutic strategies, like
individuals with hypertension. However, because our
Table 3 -Characteristics of the population according to RQ quartiles (means and prevalences)
Variables I RQ quartile (0,78 ± 0,01)
(N= 53)
II RQ quartile (0,83 ± 0,01)
(N=63)
III RQ quartile (0,87 ± 0,01)
(N=48)
IV RQ quartile (0,93 ± 0,02)
(N=59)
p
Age (years) 53 ±13 52 ± 12 53 ± 11 53 ± 11 0,922
BMI 33 ± 5 31 ± 5 31 ± 4 32 ± 5 0,053
RMR (kcal) 1509 ± 252 1433 ± 249 1535 ± 251 1571 ± 352 0,051
WC (cm) 106 ± 13 102 ± 11 100 ± 8 106 ± 14 0,064
HC (cm) 109 ± 9 109 ± 10 106 ± 7 111 ± 9 0,160
Glucose (mg/dl) 94 ± 25 95 ± 24 95 ± 21 102 ± 34 0,489
Creatinin (mg/dl) 0,79 ± 0,23 0,76 ± 0,14 0,77 ± 0,2 0,87 ± 0,76 0,595
T Cholesterol (mg/dl) 202 ± 45 205 ± 44 208 ± 44 209 ± 52 0,896
LDL (mg/dl) 126 ± 35 127 ± 40 133 ± 41 129 ± 46 0,911
HDL (mg/dl) 53 ± 17 52 ± 12 46 ± 12 50 ± 16 0,162
Triglyceride (mg/dl) 120 ± 59 130 ± 61 163 ± 127 150 ± 83 0,106
Uric acid (mg/dl) 5,25 ±1,10 5,15 ± 1,60 5,11 ± 1,40 4,95 ± 1,46 0,809
SBP (mmHg) 123 ± 11 123 ± 15 124 ± 13 130 ± 16 0,038
DBP (mmHg) 76 ± 7 74 ± 9 75 ± 9 79 ± 9 0,051
Prevalences (%)
Male 41,5 35 45,8 41 0,705
Hypertension 30 20 22 47 0,024
Diabetes Mellitus 7,5 6,4 5,7 8,9 0,948
Hyperlipidemia 54 54,3 58,3 54,3 0,976
Obesity 68 56 55,3 69 0,263
Metabolic Syndrome 0 2 6,7 5,1 0,665
Medications 4 4 5 5 0,801
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hypothetical clinical impact can be emphasized but it is
not definitely proved. The RQ measurement offers the po-
tential of a fast analyses using a low cost instrument that
is easy to use after a short period of training. However,
due to the complexity of the various ways in which differ-
ent diet may be metabolized, actually there is the need toFigure 1 Prevalence of Hypertension among RQ quartiles.perform the experiments in the same controlled condi-
tions in all individuals (for example, the same diet).
A limitation of this investigation is the cross-sectional
nature, thus this study is not able to determine tempor-
ality. Furthermore, probably the serum insulin could
contribute to help us to better explain our finding but
unfortunately in this study this parameter was lacking.
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composition (WC, HC,TBW, FM, MM, FFM) or the pres-
ence of MetS with RQ was expected, on the basis of the
similar BMI among quartiles. This finding gives strength to
our hypothesis, for which the alteration of some mecha-
nisms of fat utilization is linked to RAS and blood pressure
and not to obesity or MetS per sè. Of course future studies
with a prospective design are needed to clarify the useful-
ness of the RQ evaluation for the cardiovascular risk strati-
fication and for the prediction of the onset of hypertension.
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